Area of research
Critical Care and Intensive Care Medicine · Epidemiology
Research interest
Research interests include Sepsis Diagnosis and Treatment, Cardiac Arrest and Resuscitation, Respiratory Support and Mechanisms, and Intensive Care Unit Cognitive Disorders.
Expedited transfer from the scene for refractory out-of-hospital cardiac arrest in Australia: a prospective, multicentre, parallel, open label, randomised clinical trial
Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose-associated 90-Day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE III)
Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage
Early Sedation with Dexmedetomidine in Critically Ill Patients
Sedation Intensity in the First 48 Hours of Mechanical Ventilation and 180-Day Mortality: A Multinational Prospective Longitudinal Cohort Study*
Candida Colonization as a Risk Marker for Invasive Candidiasis in Mixed Medical-Surgical Intensive Care Units: Development and Evaluation of a Simple, Standard Protocol
Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013
Traditional landmark versus ultrasound guided tracheal puncture during percutaneous dilatational tracheostomy in adult intensive care patients: a randomised controlled trial
Half-molar sodium lactate infusion improves cardiac performance in acute heart failure: a pilot randomised controlled clinical trial
Nonleg Venous Thrombosis in Critically Ill Adults
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients
Early Intensive Care Sedation Predicts Long-Term Mortality in Ventilated Critically Ill Patients
The impact of bacterial and viral co‐infection in severe influenza
End points for Phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting